bioAffinity Technologies press release (BIAF): Q1 GAAP EPS of -$0.81. – Revenue of $1.35M.
Cash and cash equivalents as of March 31, 2026, were $3.1 million, compared with $6.4 million as of December 31, 2025
Bioaffinity Technologies GAAP EPS of -$0.81, Revenue of $1.35m
bioAffinity Technologies press release (BIAF): Q1 GAAP EPS of -$0.81. - Revenue of $1.35M. Cash and cash equivalents as of March 31, 2026, were $3.1 million, compared with $6.4 million as of December 31, 2025